MicroRNAs in tumor immunity: functional regulation in tumor-associated macrophages

Chong Chen1,2, Jia-Ming Liu1,2, Yun-Ping Luo1,2

  • 1Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences; School of Basic Medicine, Peking Union Medical College, Beijing 100005, China.

Insights

MicroRNAs (miRNAs) regulate tumor-associated macrophages (TAMs) by influencing their differentiation, polarization, and communication within the tumor microenvironment (TME). These miRNAs show potential as diagnostic markers and therapeutic targets for cancer.

Area of Science:

  • Cancer Biology
  • Immunology
  • Molecular Biology

Background:

  • Tumor-associated macrophages (TAMs) are key immune cells in the tumor microenvironment (TME), driving cancer initiation and progression.
  • MicroRNAs (miRNAs) are crucial regulators of gene expression, influencing cellular phenotypes and functions.
  • The interplay between miRNAs and TAMs significantly impacts tumor development and metastasis.

Purpose of the Study:

  • To review the regulatory roles of miRNAs in macrophage differentiation and polarization within the TME.
  • To explore the function of miRNAs in mediating crosstalk between tumor cells and macrophages.
  • To assess the potential of macrophage-related miRNAs (MRMs) as cancer biomarkers and therapeutic targets.

Main Methods:

  • Literature review focusing on the regulatory mechanisms of miRNAs in macrophage biology.
  • Analysis of signaling pathways and cellular processes influenced by miRNAs in the TME.
  • Evaluation of existing studies on MRMs for diagnostic and prognostic applications.

Main Results:

  • miRNAs are integral to myeloid cell differentiation into mature macrophages, affecting their recruitment to the TME.
  • miRNAs critically control macrophage polarization, influencing tumor-promoting or tumor-suppressing functions.
  • miRNAs, particularly exosome-encapsulated ones, mediate crucial crosstalk between tumor cells and macrophages.

Conclusions:

  • miRNAs play multifaceted roles in regulating TAMs, impacting cancer progression.
  • Macrophage-related miRNAs (MRMs) demonstrate significant potential as diagnostic and prognostic biomarkers.
  • MRM-based therapies offer a promising avenue for future cancer treatment strategies.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K